Incidental findings | Updates on Specific Topics

Main|Search|PHGKB

 

Last Posted: Sep 28, 2017

---

• Exploring the potential duty of care in clinical genomics under UK law.  
  Mitchell Colin et al. Medical law international 2017 Sep 17(3) 158-182
• CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testing.  
  Innes Josie et al. Journal of medical genetics 2017 Sep
• Genomic sequencing identifies secondary findings in a cohort of parent study participants  
  ML Thompson et al, BioRxIV, September 1, 2017
• Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research.  
  Sundby Anna et al. American journal of medical genetics. Part A 2017 Aug
• Population-based biobank participants' preferences for receiving genetic test results.  
  Yamamoto Kayono et al. Journal of human genetics 2017 Aug
• Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).  
  Ploug Thomas et al. PloS one 2017 12(7) e0179935
• Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators.  
  Kost Rhonda G et al. Journal of clinical and translational science 2017 Apr 1(2) 115-120
• Ethical considerations in genomic testing for hematologic disorders.  
  Marron Jonathan M et al. Blood 2017 Jun
• Personal utility in genomic testing: is there such a thing?  
  Bunnik Eline M et al. Journal of medical ethics 2015 Apr (4) 322-6
• Reporting practices for unsolicited and secondary findings from next generation sequencing technologies: Perspectives of laboratory personnel.  
  Vears Danya F et al. Human mutation 2017 May
• Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. 
  Mackley Michael P et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Mar 19(3) 283-293
• How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study.  
  Dheensa Sandi et al. Familial cancer 2017 Apr
• Defining categories of actionability for secondary findings in next-generation sequencing.  
  Moret Celine et al. Journal of medical ethics 2016 Dec
• Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease.  
  Fiallos Katie et al. European journal of human genetics : EJHG 2017 Mar
• Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.  
  Hegde Madhuri et al. Archives of pathology & laboratory medicine 2017 Mar
• Discussing molecular testing in oncology care: Comparing patient and physician information preferences.  
  Pinheiro Ana P M et al. Cancer 2017 Jan

more